Lifeward Ltd. 10-Q: Warrant Exercises & Reverse Split Details

Ticker: LFWD · Form: 10-Q · Filed: May 15, 2025 · CIK: 1607962

Lifeward LTD. 10-Q Filing Summary
FieldDetail
CompanyLifeward LTD. (LFWD)
Form Type10-Q
Filed DateMay 15, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, warrants, reverse-split, financials

TL;DR

Lifeward Ltd. 10-Q shows $3.5M in warrant exercises, plus reverse split info.

AI Summary

Lifeward Ltd. filed its 10-Q for the period ending March 31, 2025. The filing mentions a one-for-seven reverse share split effective March 15, 2024, and details warrant exercises from a July 2020 private placement. As of March 31, 2025, 288,634 warrants were exercised for $3,556,976.

Why It Matters

This filing provides insight into Lifeward Ltd.'s financial structure and recent capital raising activities, including the impact of warrant exercises and a past reverse stock split.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.

Key Numbers

Key Players & Entities

FAQ

What was the total number of warrants exercised as of March 31, 2025?

As of March 31, 2025, 288,634 warrants were exercised.

What was the total consideration received for the exercised warrants?

The total consideration received for the exercised warrants was $3,556,976.

When did the one-for-seven reverse share split become effective?

The one-for-seven reverse share split became effective on March 15, 2024.

Were any warrants exercised during the three months ending March 31, 2025?

No, during the three months that ended March 31, 2025, no warrants were exercised.

What is Lifeward Ltd.'s SIC code and industry?

Lifeward Ltd.'s Standard Industrial Classification (SIC) code is 3842, for Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Lifeward Ltd. (LFWD).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing